More than 15 years ago, Yale's Gail D'Onofrio started studying the effectiveness of sublingual (under-the-tongue) buprenorphine for treatment of opioid use disorder (OUD) in the emergency department.

One man who misused the medication has shared the “catastrophic” results, while an undercover News Corp investigation found a telehealth provider indicated it was willing to provide the injections to ...